4//SEC Filing
Powell Lynne 4
Accession 0001127602-19-002527
CIK 0000882796other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:12 PM ET
Size
8.0 KB
Accession
0001127602-19-002527
Insider Transaction Report
Form 4
Powell Lynne
Senior VP - CCO
Transactions
- Exercise/Conversion
Common Stock
2019-01-18$3.22/sh+2,000$6,440→ 2,000 total - Sale
Common Stock
2019-01-18$9.40/sh−2,000$18,800→ 0 total - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2019-01-18−2,000→ 91,427 totalExercise: $3.22From: 2017-05-23Exp: 2026-05-23→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001631667
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 4:12 PM ET
- Size
- 8.0 KB